Target intelligence / Profile preview

RNA, U6 small nuclear 463, pseudogene (RNU6-463P)

Target: RNU6-463P
Molecular classification: Pseudogene, Non-coding RNA (specifically, a non-functional snRNA pseudogene), Other (does not belong to receptor, channel, transporter, enzyme, or transcription factor families)

Overview

RNU6-463P is a human pseudogene derived from the U6 small nuclear RNA gene family. U6 snRNA is a crucial, highly conserved non-coding RNA component of the spliceosome, essential for pre-mRNA splicing[1][3]. Pseudogenes such as RNU6-463P do not encode functional snRNAs, though the genomic sequence may resemble genuine U6 snRNA. Pseudogene formation may involve duplications or sequence rearrangements and typically results in transcriptionally silent or non-functional RNAs[5]. Some pseudogenes in general have regulatory functions at the RNA level, but there is no evidence that RNU6-463P affects cellular processes, disease, or drug response. It is best classified as a non-functional, non-coding pseudogene, not a pharmacological receptor or therapeutic target[5][3][4].

Other names: RNU6-463PRNA, U6 small nuclear 463, pseudogene

Mechanism of action

None. No drugs are known to modulate pseudogene RNA directly.

Biological functions

No confirmed biological function for RNU6-463P specifically; as a pseudogene of U6 snRNA, it may have no activity.General roles of pseudogenes can include regulation of parental gene expression, functioning as endogenous competing RNAs, miRNA sponges, or contributing to epigenetic regulation, but specific evidence for RNU6-463P is lacking.

Disease associations

Other (no direct disease involvement established for RNU6-463P)Generally, some pseudogenes have been implicated in cancer and other diseases via regulatory mechanisms, but not this specific molecule.

Beyond the preview

Go deeper on RNA, U6 small nuclear 463, pseudogene (RNU6-463P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 463, pseudogene (RNU6-463P).

Explore the full profile